117 related articles for article (PubMed ID: 3458082)
21. Cervical changes associated with progestagen-only contraceptives: a team approach.
Darwish A; Labeeb S; Galal M; Rashad H; Hassan S
Contraception; 2004 Feb; 69(2):121-7. PubMed ID: 14759616
[TBL] [Abstract][Full Text] [Related]
22. Intraepithelial cervical neoplasia in women using intrauterine devices and long-acting injectable progestogens as contraceptives.
Dabancens A; Prado R; Larraguibel R; Zañartu J
Am J Obstet Gynecol; 1974 Aug; 119(8):1052-6. PubMed ID: 4136245
[No Abstract] [Full Text] [Related]
23. [Intrauterine contraception and carcinoma in situ].
Ruud TE; Aarstrand T
Tidsskr Nor Laegeforen; 1975 Nov; 95(32):1845-7. PubMed ID: 1198564
[No Abstract] [Full Text] [Related]
24. Cellular composition of cervical smears in relation to the day of the menstrual cycle and the method of contraception.
Vooijs GP; van der Graaf Y; Elias AG
Acta Cytol; 1987; 31(4):417-26. PubMed ID: 3604536
[TBL] [Abstract][Full Text] [Related]
25. Contraception continuation rates and reasons for discontinuation in Zahedan, Islamic Republic of Iran.
Rakhshani F; Mohammadi M
East Mediterr Health J; 2004 May; 10(3):260-7. PubMed ID: 16212200
[TBL] [Abstract][Full Text] [Related]
26. Safety and efficacy of fertility-regulating methods: a decade of research.
Skegg DC
Bull World Health Organ; 1999; 77(9):713-21. PubMed ID: 10534894
[TBL] [Abstract][Full Text] [Related]
27. Influence of oral contraception on cytology and histology of the cervix uteri. Population screening for cervical carcinoma in Maribo amt 1967-1969.
Berget A; Weber T
Dan Med Bull; 1974 Aug; 21(5):172-6. PubMed ID: 4852441
[TBL] [Abstract][Full Text] [Related]
28. Dysplasia and the pill--a progress report on the American Women's Health Program.
Hontz AC; Balin H; Merritt CG; LoSciuto A
J Reprod Med; 1974 Sep; 13(3):101-5. PubMed ID: 4412876
[TBL] [Abstract][Full Text] [Related]
29. Contraception in the later reproductive years: a valid aspect of preventive health care.
Speroff L; Sulak PJ
Dialogues Contracept; 1995; 4(5):1-4. PubMed ID: 12288679
[TBL] [Abstract][Full Text] [Related]
30. European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
Serfaty D; Wildemeersch D; Verougstraete A; Creatsas G
Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():73-9. PubMed ID: 8574253
[TBL] [Abstract][Full Text] [Related]
31. [Contraceptive use in women with heart disease].
Avila WS; Grinberg M; Melo NR; Aristodemo Pinotti J; Pileggi F
Arq Bras Cardiol; 1996 Apr; 66(4):205-11. PubMed ID: 8935685
[TBL] [Abstract][Full Text] [Related]
32. A comparative analysis of the modification of sexual desire of users of oral hormonal contraceptives and intrauterine contraceptive devices.
Martin-Loeches M; Ortí RM; Monfort M; Ortega E; Rius J
Eur J Contracept Reprod Health Care; 2003 Sep; 8(3):129-34. PubMed ID: 14667322
[TBL] [Abstract][Full Text] [Related]
33. Prospective long-term study of women on different contraceptives.
IPPF Med Bull; 1976 Oct; 10(5):2-3. PubMed ID: 12307439
[TBL] [Abstract][Full Text] [Related]
34. Intrauterine devices: an effective alternative to oral hormonal contraception.
Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
[TBL] [Abstract][Full Text] [Related]
35. [Proliferative mucosal changes of the corpus and cervix uteri in women using intrauterine contraceptives].
Petrov IuA; Kovaleva EA
Vopr Onkol; 1986; 32(3):49-52. PubMed ID: 3962257
[TBL] [Abstract][Full Text] [Related]
36. Steroid contraception and dysplasia of the cervix: an interim report.
Stern E; Coffelt CF; Youkeles L; Forsythe A
J Reprod Med; 1973 Apr; 10(4):177-83. PubMed ID: 4695500
[No Abstract] [Full Text] [Related]
37. The state of the contraceptive art.
Tyrer LB; Duarte J
Plan Parent Rev; 1983; 3(2):5-7. PubMed ID: 12265618
[TBL] [Abstract][Full Text] [Related]
38. [Contraception and carcinogenic risks].
Cappelaere P
Lille Med; 1971; 16():45-51. PubMed ID: 4926823
[No Abstract] [Full Text] [Related]
39. [Oral contraceptives and cancer of the cervix uteri. Analysis of the strength of the association].
Rodríguez-Contreras R; Delgado Rodríguez M; Sillero Arenas M; Lardelli Claret P; Gálvez Vargas R
Rev Sanid Hig Publica (Madr); 1991; 65(1):25-38. PubMed ID: 1839333
[TBL] [Abstract][Full Text] [Related]
40. Use of the New Zealand Intensive Medicines Monitoring Programme to study the levonorgestrel-releasing intrauterine device (Mirena).
Zhou L; Harrison-Woolrych M; Coulter DM
Pharmacoepidemiol Drug Saf; 2003; 12(5):371-7. PubMed ID: 12899110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
